))
Here Wegovy! Medicare Coverage for Heart Disease
Manage episode 411932344 series 3531512
コンテンツは Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Episode 20 of The Pound of Cure Weight Loss podcast is titled, Here Wegovy: Medicare Coverage for Heart Disease. We called it that because of the NPR article we cover in our In the News segment which states that Medicare will now cover Wegovy for patients who are overweight and suffer from heart disease. How does this impact the future of GLP-1 medications? Tune in to find out.
In our Patient Story, we talk to Larry. He came to us after receiving a high blood pressure diagnosis from his primary care physician. He didn’t want to take medication for the rest of his life so he decided to embrace a gastric bypass and has surpassed our expectations of weight loss by combining the surgical tool with weight training. It’s a truly inspiring story.
In our Nutrition segment, Zoe offers her #1 tip for grocery shopping that will encourage you to be successful in your weight loss efforts.
Our Economics of Obesity segment covers the GLP-1 shortage. Mounjaro, Wegovy, Zepbound, Saxenda, Trulicity, and Ozempic are on the shortage list. So we are offering some creative solutions to get you through.
Finally, we answer 3 of our listener’s questions including, fluid choices for energy and hydration, whether or not revision surgery causes the same amount of weight loss as the initial surgery, and exercise recommendations after weight loss surgery.
If you have a question that you'd like for us to answer on the podcast, please reach out to us through social media (Instagram, Tik Tok, Facebook or YouTube), or the website.
24 つのエピソード
シェア
